Literature DB >> 26621457

MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.

Hélène Denis1, Olivier Van Grembergen1, Benjamin Delatte1, Sarah Dedeurwaerder1, Pascale Putmans1, Emilie Calonne1, Françoise Rothé2, Christos Sotiriou2, François Fuks1, Rachel Deplus1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. Alteration of miRNA levels is common in tumors and contributes to the pathogenesis of human malignancies. In the present study we examined the role played by miR-137 in breast tumorigenesis. We found miR-137 levels to be lower in breast cancer cells than in their non-tumorigenic counterparts and observed reduced proliferation and migration of breast cancer cells overexpressing miR-137. We further identified KDM5B, a histone demethylase known to be involved in breast cancer tumorigenesis, as a target of miR-137. As the involvement of histone demethylases in cancer is still poorly understood and as the role of miRNAs in controlling epigenetic mechanisms in cancer is emerging, we broadened our study to the whole KDM5 histone demethylase family to see if the genes coding for these epigenetic enzymes might be regulated by miRNAs in cancer cells. We discovered that KDM5C is overexpressed in breast cancer cells, providing evidence that miR-138 regulates its expression. We found miR-138 overexpression to affect breast cancer cell proliferation. Altogether, our findings suggest that miRNAs may regulate KDM5 histone demethylase levels in breast cancer and thereby control breast cancer cell proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26621457     DOI: 10.1039/c5mb00513b

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  11 in total

Review 1.  The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.

Authors:  Thomas Kietzmann; Andreas Petry; Antonina Shvetsova; Joachim M Gerhold; Agnes Görlach
Journal:  Br J Pharmacol       Date:  2017-05-10       Impact factor: 8.739

2.  Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.

Authors:  Katarzyna Szarc Vel Szic; Ken Declerck; René A J Crans; Jolien Diddens; David B Scherf; Clarissa Gerhäuser; Wim Vanden Berghe
Journal:  Oncotarget       Date:  2017-06-20

3.  JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer.

Authors:  Ivano Mocavini; Simone Pippa; Valerio Licursi; Paola Paci; Daniela Trisciuoglio; Cecilia Mannironi; Carlo Presutti; Rodolfo Negri
Journal:  Cancer Sci       Date:  2019-03-18       Impact factor: 6.716

Review 4.  MicroRNAs overexpressed in Crohn's disease and their interactions with mechanisms of epigenetic regulation explain novel aspects of Crohn's disease pathogenesis.

Authors:  Cecilia Fernández-Ponce; Roberto Navarro Quiroz; Anderson Díaz Perez; Gustavo Aroca Martinez; Andrés Cadena Bonfanti; Antonio Acosta Hoyos; Lorena Gómez Escorcia; Sandra Hernández Agudelo; Christian Orozco Sánchez; José Villarreal Camacho; Linda Atencio Ibarra; Jose Consuegra Machado; Alberto Espinoza Garavito; Francisco García-Cózar; Elkin Navarro Quiroz
Journal:  Clin Epigenetics       Date:  2021-02-18       Impact factor: 6.551

5.  KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a.

Authors:  Quan Zhang; Lei Xu; Jianjun Wang; Xiaoming Zhu; Zeheng Ma; Junfeng Yang; Jiwei Li; Xiangbo Jia; Li Wei
Journal:  Onco Targets Ther       Date:  2021-02-22       Impact factor: 4.147

6.  Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line.

Authors:  Xiao-Jie Xue; Fei-Rong Li; Jing Yu
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

Review 7.  Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.

Authors:  Deniz Mortazavi; Behnoush Sohrabi; Meysam Mosallaei; Ziba Nariman-Saleh-Fam; Milad Bastami; Yaser Mansoori; Abdolreza Daraei; Sepideh Zununi Vahed; Shadan Navid; Zahra Saadatian; Tannaz Jamialahmadi; Yong Teng; Amirhossein Sahebkar
Journal:  J Oncol       Date:  2022-01-11       Impact factor: 4.375

8.  HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression

Authors:  YuYing Cui; Chao Lv; Yu Wen; Dongmei Zhao; Yu Yang; Hongbin Qiu; Chennan Wang
Journal:  Balkan Med J       Date:  2021-12-20       Impact factor: 2.021

9.  KDM5 histone demethylases repress immune response via suppression of STING.

Authors:  Lizhen Wu; Jian Cao; Wesley L Cai; Sabine M Lang; John R Horton; Daniel J Jansen; Zongzhi Z Liu; Jocelyn F Chen; Meiling Zhang; Bryan T Mott; Katherine Pohida; Ganesha Rai; Stephen C Kales; Mark J Henderson; Xin Hu; Ajit Jadhav; David J Maloney; Anton Simeonov; Shu Zhu; Akiko Iwasaki; Matthew D Hall; Xiaodong Cheng; Gerald S Shadel; Qin Yan
Journal:  PLoS Biol       Date:  2018-08-06       Impact factor: 9.593

10.  Comparison of miRNA Profiles of Cord Blood Stem Cells in Identical and Fraternal Twins.

Authors:  Monireh Ajami; Mohammad Hadi Sadeghian; Masoud Soleimani; Mohammad Reza Keramati; Mansoureh Ajami; Azadeh Anbarlou; Amir Atashi
Journal:  Cell J       Date:  2018-11-18       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.